UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

March 5, 2024

NAPCO SECURITY TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

Registrant's telephone number, including area code:  (631) 842-9400

____________________________________________________

(Former name or former address, if changed from last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (section 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (section 240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ¨

Item 1.01. Entry into Material Agreement.

On March 5, 2024, NAPCO Security Technologies, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Needham & Company, LLC and Cowen and Company, LLC (the “Underwriters”) and the Company’s President, Chief Executive Officer and Chairman of the Board of Directors, Richard L. Soloway (the “Selling Stockholder”), relating to the sale by the Selling Stockholder of an aggregate of 2,000,000 shares of the Company’s common stock, $0.01 par value per share (the “Common Stock”) owned by the Selling Stockholder in an underwritten secondary public offering, at a price to the public of $40.75 per share. The Selling Stockholder will pay any underwriting discounts and commissions and expenses incurred by the Selling Stockholder in the offering. Pursuant to the Underwriting Agreement, the Selling Stockholder also granted the Underwriters a 30-day option to purchase from the Selling Stockholder up to an aggregate of 300,000 additional shares of common stock at the public offering price, less the underwriting discount. The Company will not receive any proceeds from the sale of shares of common stock by the Selling Stockholder, nor will the Company be issuing any shares in connection with the offering. The offering is expected to close on or about March 8, 2024, subject to the satisfaction of customary closing conditions contained in the Underwriting Agreement.

The Underwriting Agreement contains customary representations, warranties and agreements by the Company and the Selling Stockholder, customary conditions to closing, indemnification obligations of the Company, the Selling Stockholder and the Underwriters, including for liabilities under the Securities Act of 1933, as amended, other obligations of the parties and termination provisions.

The secondary public offering by the Selling Stockholder is being made pursuant to the Company’s registration statement on Form S-3ASR (Registration Statement No. 333-277663), filed with the Securities and Exchange Commission (the “SEC”) on March 5, 2024, and which became automatically effective on filing, the preliminary prospectus supplement, together with the accompanying prospectus, filed with the SEC on March 5, 2024, and a final prospectus supplement, together with the accompanying prospectus, that was filed with the SEC on March 7, 2024. The foregoing is only a brief description of the terms of the Underwriting Agreement, does not purport to be a complete statement of the rights and obligations of the parties under the Underwriting Agreement and the transactions contemplated thereby, and is qualified in its entirety by reference to a copy of the Underwriting Agreement which is attached as Exhibit 1.1 hereto.

On March 5, 2024, the Company issued a press release announcing the pricing of the secondary offering. A copy of such press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated into this Item 1.01 by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunder duly authorized.